| 1 |
30135178 | Organic Anion Transporter 2-Mediated Hepatic Uptake Contributes to the Clearance of High-Permeability-Low-Molecular-Weight Acid and Zwitterion Drugs: Evaluation Using 25 Drugs. | 2018 Nov |
1 |
| 2 |
22842957 | Effect of CYP2C9 and SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of nateglinide in healthy Chinese male volunteers. | 2013 Mar |
3 |
| 3 |
22221095 | Contribution of organic anion transporting polypeptide (OATP) 1B1 and OATP1B3 to hepatic uptake of nateglinide, and the prediction of drug-drug interactions via these transporters. | 2012 Feb |
6 |
| 4 |
20406215 | SLCO1B1 polymorphism and oral antidiabetic drugs. | 2010 Oct |
1 |
| 5 |
18187595 | Different effects of SLCO1B1 polymorphism on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide. | 2008 Mar |
1 |
| 6 |
18854776 | Effects of the SLCO1B1*1B haplotype on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide. | 2008 Nov |
4 |
| 7 |
16796707 | Effect of SLCO1B1 genetic polymorphism on the pharmacokinetics of nateglinide. | 2006 Nov |
3 |